Clinical/Scientific Note

Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder

  1. Svenja Happe MD1,*,
  2. Martin Sommer MD1,
  3. Johannes Meller MD2,
  4. Claudia Trenkwalder MD1,
  5. Walter Paulus MD1

Article first published online: 10 AUG 2004

DOI: 10.1002/mds.20274

Issue

Movement Disorders

Movement Disorders

Volume 20, Issue 1, pages 105–108, January 2005

Additional Information

How to Cite

Happe, S., Sommer, M., Meller, J., Trenkwalder, C. and Paulus, W. (2005), Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder. Movement Disorders, 20: 105–108. doi: 10.1002/mds.20274

Author Information

  1. 1

    Department of Clinical Neurophysiology, University of Göttingen, Germany

  2. 2

    Department of Nuclear Medicine, University of Göttingen, Germany

*Department of Clinical Neurophysiology, University of Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany

Publication History

  1. Issue published online: 12 JAN 2005
  2. Article first published online: 10 AUG 2004
  3. Manuscript Accepted: 1 FEB 2004
  4. Manuscript Revised: 31 JAN 2004
  5. Manuscript Received: 28 NOV 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (98K)

Keywords:

  • drug-induced dyskinesia;
  • psychogenic parkinsonism;
  • apomorphine;
  • choreatiform dyskinesia

Abstract

Dyskinesias are known to occur in many patients with Parkinson's disease treated with dopaminergic drugs but to date, drug-induced dyskinesias have not been observed in humans with no underlying basal ganglia disorder. We describe a patient with psychogenic parkinsonism and intravenous apomorphine abuse leading to subsequent choreatiform dyskinesias. © 2004 Movement Disorder Society

View Full Article (HTML) Get PDF (98K)